2 unknown, 1 completed. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow 24,25-oxidolanosterol: new trials by email Literature Review of 24,25-oxidolanosterol trials Research Report on 24,25-oxidolanosterol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reaching Motion During Functional Activities IMU (Inertial Measurement Devices) - Shoulder Arthropathy Associated With Other Conditions, Healthy | Not applicable | Unknown | University Hospital, Ghent | 100 | 2023-10-15 | 2023-12-08 |
| Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects MRI evaluation, Actimetry & IMU, Gait evaluation - Motoric Cognitive Risk Syndrome, Mild Cognitive Impairment | Unknown | University Hospital, Caen | 160 | 2022-01-26 | 2022-12-07 | |
| Cbt for Psychosis and Affect on Psychosis Symptoms cognitive behaviour therapy, Espidone, Olepra - Psychosis | Phase 2 | Completed | Aisha Andleeb | 50 | 2015-09-01 | 2016-01-13 |
Alzheimer Disease (1) · Cognitive Dysfunction (1) · Dementia (1) · Psychotic Disorders (1)
Aisha Andleeb (1) · University Hospital, Caen (1) · University Hospital, Ghent (1)
Belgium (1) · France (1)
Alexander Van Tongel, PhD (1) · Ann Cools, PhD (1) · Annelies Maenhout, PhD (1) · Pierre Denise, MD, PhD (1)